McKesson
1
Recalls
0
Units Recalled
0
Injuries
0
Deaths
Categories: Drug
2026-07-08 to 2026-07-08
| Date | Source | Product | Brand | Severity | Units |
|---|---|---|---|---|---|
| 2026-07-08 | FDA Drug | FDA Recall: Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusio | McKesson | Class II | N/A |